Many patients notice small shifts of a few pounds often related to changes in appetite, water balance, or dietary patterns rather than dramatic weight changes right away
References: Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.2023
And then I even had a handful of patients that were taking less frequently than that, and people maintaining their weight doing that. Is it safe to microdose a GLP-1 drug
The drug can slow down breathing and may cause coma or death
Eine solche Auswertung erfolgt insbesondere gem Art
Semaglutide with B12 has the same contraindications and potential side effects as semaglutide, including the risk of thyroid C-cell cancer (such as multiple endocrine neoplasia syndrome type 2), pancreatitis, hypoglycemia, and serious allergic reactions